Pi Pharma Intelligence’s Contributions Extend Beyond the Pharmaceutical Industry to Include Academia
AchievementWe are glad to see Pi Pharma Intelligence rising as a trusted provider of data, Today marks our first contribution to an article published at the Annals of Pharmacotherapy on Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma with BRAF Mutation, we thank all the authors for their trust and special thanks to our advisor Dr.Nimer Alkhatib
Shaping the Future of Pharma: Eng. Nusaibah Al-Jaloudi Speaking at GCC Regulatory Affairs Summit
Jan, 2025
Eng. Nusaibah Al-Jaloudi, CEO of PI Pharma Intelligence, will speak at the 10th GCC Regulatory Affairs Pharma Summit, sharing her expertise in healthcare, pharmaceuticals, and innovation.
Pi Pharma Team will attend CPHI Barcelona 2023
Aug, 2023
Pi Pharma Team will attend CPHI Barcelona 2023
A Visit That Matters đŸ’™
Jul, 2025
The Pi Pharma team had the privilege of visiting Nazik Al Hariri center for special education as part of our social responsibility efforts.